Logo

research alliance

Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer

This clinical study, called Sculptor, is the first research to emerge from a strategic collaboration between the companies on oncology therapeutics.

Envisagenics, Bristol Myers Squibb Partner to ID Cancer Therapy Alternative Splice Targets

Envisagenics will use its SpliceCore platform to identify alternative splicing-derived therapeutic targets for BMS's cancer pipeline.

Owkin, Stanford Medicine Collaborate on AI-Driven Lung Cancer, Mesothelioma Biomarker Discovery

The French bioinformatics firm will analyze molecular and other multimodal data in search of new cancer therapeutics.

Metabolon, Parkinson's UK Form Biomarker Discovery Alliance

Metabolon will participate in a Parkinson's UK-funded study to map metabolic changes in serum that can serve as biomarkers of disease progression.

St. Jude, Broad Institute, Dana-Farber Partner to Advance Pediatric Cancer Research

The institutions have invested $60 million into the Pediatric Cancer Dependencies Accelerator to study cancer vulnerabilities and develop treatments.

Sep 27, 2022

Metabolon, NTU Singapore Partner for Disease Biomarker Discovery Study

Sep 12, 2022

Broad Institute, Datavant Strike Health Data Alliance

Aug 24, 2022

Mount Sinai Million Health Discoveries Program Represents New Ground for Partner Regeneron
Premium

Jun 30, 2022

MultiOmic Health, Mesh Bio Partner to Study Chronic Metabolic Disease for Drug, Dx Development

Jun 7, 2022

Metabolon, King's College London Partner to Study Twin Microbiomes

Jun 2, 2022

Caris, Sorrento, Prostate Cancer Clinical Trial Consortium Ink Clinical Trial Partnership

Jun 1, 2022

Avera Health, Sema4 Launch Five-Year Precision Oncology Study

May 26, 2022

54gene Leads Consortium to Sequence 100K Nigerian Genomes, Plans to Expand Continent-Wide
Premium

May 13, 2022

BC Platforms Partners With Finnish Biobanks for Therapeutics Research

Apr 28, 2022

Dante Labs, Abu Dhabi Stem Cells Center Ink Genetic Testing, mRNA Cancer Vaccine Development Deal

Apr 13, 2022

Nurosene Health, Ontario Institute for Cancer Research Team for Pancreatic Cancer Research

Apr 12, 2022

In Sixth Year, Project GENIE Diversifying, Integrating Local Ancestry and Enhancing Clinical Data
Premium

Apr 8, 2022

Tempus Sets Sights on Pathology Market With New Informatics, Research Network
Premium

Mar 2, 2022

BC Platforms Partners with SingHealth for Research, Opens R&D Center in Singapore

Jan 18, 2022

NHS, Genomics PLC to Integrate Polygenic Risk Scores With Traditional Cardiovascular Risk Factors

Jan 13, 2022

Eagle Genomics, Quadram Institute Form Microbiome Data Research Alliance

Jan 11, 2022

Seqster, National Pancreas Foundation Partner on Pancreatic Disease Registry

Nov 18, 2021

Exact Sciences, Jefferson Health to Study Blood-Based Multicancer Early Detection Test

Nov 18, 2021

Helix, Cue Health Partner on SARS-CoV-2 Variant Sequencing Study

Oct 12, 2021

Partnership Aims to Sequence African Genomes in Fight for Health Equity
Premium

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.